HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuya Tsunoda Selected Research

arginyl- phenylalanyl- valyl- prolyl- aspartyl- glycyl- asparagyl- arginyl- isoleucine

7/2015Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.
12/2012Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuya Tsunoda Research Topics

Disease

59Neoplasms (Cancer)
12/2022 - 03/2002
14Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 03/2002
9Testicular Neoplasms (Testicular Cancer)
01/2018 - 08/2005
8Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 10/2008
8Stomach Neoplasms (Stomach Cancer)
12/2021 - 03/2002
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 12/2008
5Lung Neoplasms (Lung Cancer)
01/2018 - 03/2002
4Colonic Neoplasms (Colon Cancer)
07/2022 - 12/2004
4Neoplasm Metastasis (Metastasis)
03/2022 - 06/2002
4Esophageal Neoplasms (Esophageal Cancer)
04/2014 - 11/2007
4Esophageal Squamous Cell Carcinoma
04/2014 - 07/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 02/2021
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2022 - 01/2005
2Residual Neoplasm
02/2022 - 04/2014
2Carcinoma (Carcinomatosis)
06/2021 - 07/2004
2Melanoma (Melanoma, Malignant)
02/2021 - 03/2002
2Renal Cell Carcinoma (Grawitz Tumor)
01/2014 - 12/2008
1Obesity
07/2022
1Pain (Aches)
03/2022
1Colitis
03/2022
1Diarrhea
03/2022
1Hemorrhage
03/2022
1Ulcer
03/2022
1Respiratory Sounds (Crackle)
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Disease Progression
12/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2021
1Cholangitis
06/2021
1Sclerosing Cholangitis
06/2021
1Abdominal Pain (Pain, Abdominal)
06/2021
1Hepatitis
06/2021
1Liver Neoplasms (Liver Cancer)
03/2021

Drug/Important Bio-Agent (IBA)

29Peptides (Polypeptides)IBA
05/2018 - 07/2003
21EpitopesIBA
05/2018 - 07/2003
21AntigensIBA
01/2018 - 07/2003
12Complementary DNA (cDNA)IBA
06/2016 - 07/2003
11Messenger RNA (mRNA)IBA
02/2022 - 03/2002
9Cancer VaccinesIBA
01/2016 - 07/2003
7Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2004
7Protein Subunit VaccinesIBA
07/2014 - 11/2008
6Immune Checkpoint InhibitorsIBA
12/2022 - 09/2019
6Pharmaceutical PreparationsIBA
07/2022 - 08/2006
6Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2016 - 11/2007
6Carrier Proteins (Binding Protein)IBA
06/2016 - 07/2003
5Protein Kinases (Protein Kinase)IBA
04/2014 - 11/2007
5HLA-A*02:01 antigenIBA
10/2006 - 12/2004
4Biomarkers (Surrogate Marker)IBA
04/2022 - 03/2021
4HLA-A Antigens (HLA-A)IBA
05/2018 - 12/2004
4VaccinesIBA
05/2018 - 12/2012
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2015 - 06/2005
4Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2014 - 10/2006
4HLA-A24 AntigenIBA
04/2011 - 07/2004
3Irinotecan (Camptosar)FDA LinkGeneric
05/2022 - 01/2021
3EnzymesIBA
12/2021 - 08/2009
3GemcitabineFDA Link
07/2015 - 11/2008
3HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2014 - 10/2008
3Cadherins (E-Cadherin)IBA
08/2012 - 10/2008
3Insulin-Like PeptidesIBA
08/2009 - 11/2007
2Therapeutic UsesIBA
12/2022 - 02/2022
2Imatinib Mesylate (Gleevec)FDA Link
07/2022 - 01/2005
2regorafenibIBA
04/2022 - 01/2020
2NivolumabIBA
06/2021 - 05/2021
2Capecitabine (Xeloda)FDA Link
01/2020 - 01/2019
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 01/2019
2arginyl- phenylalanyl- valyl- prolyl- aspartyl- glycyl- asparagyl- arginyl- isoleucineIBA
07/2015 - 12/2012
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2014 - 08/2013
2KinesinsIBA
08/2013 - 01/2012
2Small Interfering RNA (siRNA)IBA
08/2006 - 08/2005
2Carcinoembryonic AntigenIBA
07/2004 - 07/2003
1Chimeric Antigen ReceptorsIBA
12/2022
1A 7 (A-7)IBA
07/2022
1L-methionine gamma-lyaseIBA
05/2022
1Fluorouracil (Carac)FDA LinkGeneric
05/2022
1folfirinoxIBA
05/2022
1Leucovorin (Folinic Acid)FDA Link
05/2022
1micaIBA
04/2022
1EverolimusFDA Link
03/2022
1montelukast (Singulair)FDA Link
01/2022
1pembrolizumabIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1CTLA-4 AntigenIBA
01/2022
1AntibodiesIBA
12/2021
1ImmunosorbentsIBA
12/2021
1Arginine (L-Arginine)FDA Link
11/2021
1Leucine (L-Leucine)FDA Link
11/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2021
1Alanine Transaminase (SGPT)IBA
06/2021
1BilirubinIBA
06/2021
1Prednisolone (Predate)FDA LinkGeneric
06/2021
1Biological ProductsIBA
03/2021
1Ephrin-A1 (Ephrin A1)IBA
03/2021

Therapy/Procedure

22Immunotherapy
12/2022 - 07/2003
20Therapeutics
12/2022 - 03/2002
6Drug Therapy (Chemotherapy)
12/2022 - 02/2005
2Aftercare (After-Treatment)
01/2020 - 09/2019
1Isogeneic Transplantation
07/2022
1Transplantation
07/2022
1Sutures (Suture)
07/2022